Endoscopy 2004; 36(12): 1123-1125
DOI: 10.1055/s-2004-826118
SFED Guidelines
© Georg Thieme Verlag KG Stuttgart · New York

Antibiotic Prophylaxis for Digestive Endoscopy

M.  Barthet1 , B.  Napoleon1 , G.  Gay1 , T.  Ponchon1 , D.  Sautereau1 , J.  P.  Arpurt1 , C.  Boustiere1 , J.  Boyer1 , J.  M.  Canard1 , P.  A.  Dalbies1 , J.  Escourrou1 , M.  Greff1 , J.  Lapuelle1 , R.  Laugier1 , J.  C.  Letard1 , B.  Marchetti1 , L.  Palazzo1 , B.  Vedrenne1
  • 1Société Française d’Endoscopie Digestive (SFED)
Caution: These guidelines were finalized on August 2003. It is the responsibility of every practitioner to keep up to date with the latest scientific information.
Further Information

Publication History

Publication Date:
01 December 2004 (online)

Introduction

The aim in antibiotic prophylaxis is to prevent general and local infectious complications related to a medical procedure. General complications are rare in digestive endoscopy (five cases of endocarditis have been reported in the English-language literature [1]), but the rate of local complications can reach 1 % for certain procedures (such as endoscopic retrograde cholangiopancreatography, ERCP).

The benefits of antibiotic prophylaxis should be weighed up against:

Its cost, which is not negligible (depending on the number of endoscopies carried out). The risk of selecting resistant bacteria 2 3 4 5 6 7. The lack of absolute efficacy in preventing endocarditis and local infections, as noted in controlled studies. The high levels of bacteremia also reported in everyday procedures (such as cleaning the teeth). The risk of causing anaphylactic shock or allergic symptoms, the severity of which may be variable.

The use of antibiotic prophylaxis must be justified. These recommendations take into account both the risks associated with the endoscopic procedure and risks inherent to the patients themselves.

References

  • 1 Oliver G, Lowry A, Hicks T. et al . Practice parameters for antibiotic prophylaxis: supporting documentation.  Dis Colon Rectum. 2000;  43 1194-1200
  • 2 Rey J R, Axon A, Budzynska A. et al . Guidelines of the European Society of Gastrointestinal Endoscopy (ESGE): antibiotic prophylaxis for gastrointestinal endoscopy.  Endoscopy. 1998;  30 318-324
  • 3 American Society for Gastrointestinal Endoscopy. Infection control during gastrointestinal endoscopy.  Gastrointest Endosc. 1999;  49 836-841
  • 4 American Society for Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy.  Gastrointest Endosc. 1995;  42 630-635
  • 5 Mani V, Cartwright K, Dooley J. et al . Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a working party for the British Society of Gastroenterology Endoscopy committee.  Endoscopy. 1997;  29 114-119
  • 6 Greff M, SFED. Antibioprophylaxie en endoscopie digestive.  Endoscopy. 1998;  30 I-III
  • 7 Schembre D, Bjorkman D J. Endoscopy-related infections.  Aliment Pharmacol Ther. 1993;  7 347-355
  • 8 Dajani A S, Tabuert K, Wilson W. et al . Prevention of bacterial endocarditis: recommendations by the American Heart Association.  JAMA. 1997;  277 1794-1801
  • 9 Sharma V K, Howden C W. Meta-analysis of randomized controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy.  Am J Gastroenterol. 2000;  95 3133-3136
  • 10 Külling D, Sonnenberg A, Fried M. et al . Cost analysis of antibiotic prophylaxis for PEG.  Gastrointest Endosc. 2000;  51 152-156
  • 11 Subhani J M, Kibbler C, Dooley J S. Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP).  Aliment Pharmacol Ther. 1999;  13 103-116
  • 12 Harris A, Chan A C, Torres-Viera C. et al . Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP).  Endoscopy. 1999;  31 718-724
  • 13 Lorenz R, Herrmann M, Kassem A M. et al . Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system.  Endoscopy. 1998;  30 708-712
  • 14 [Anon] . Prophylaxie de l’endocardite infectieuse. Révision de la Conférence de Consensus de mars 1992 - recommandations 2002.  Med Mal Infect. 2002;  32 533-541
    >